Mucormycosis is a form of fulminant invasive fungal infection of the sinonasal tract that often extends to the orbit, brain, palate, and skin. It is caused by members of the order Mucorales, and it is considered to be the most fatal fungal infection known to man. It is most commonly associated with diabetic ketoacidosis, hematologic malignancies, acquired immunodeficiency syndrome acquired immunodeficiency syndrome, see AIDS. , and immunosuppressive therapy. This rare opportunistic infection exists in many forms, the most 
Introduction
Mucormycosis is a rapidly progressive fungal infection that usually develops in patients who are metabolically or immunologically compromised. Left untreated, it is rapidly fatal. Thereby Mucormycosis has earned its designation as the most acutely fatal fungal infection known to man. 1 Saprophytes (band), a Lithuanian gothic/deat MMucormycosis is caused by Saprophytic aerobic fungi of the Phycomycetes class (order Mucorales) . 2 Saprotroph, a term used for organisms which obtain nutrients from dead organic matter (this term commonly applies to fungi)· These saprophytes are commonly found in soil, decomposed vegetation, and in the healthy human respiratory and digestive tracts, and their distribution is worldwide.
Mucormycosis can manifest as one of six different clinical syndromes; it appears in rhinocerebral, pulmonary, gastrointestinal, central nervous system, subcutaneous, and disseminated forms. Rhinocerebral mucormycosis (RCM) is the most common of these forms, and it is subdivided into three subtypes: rhinomaxillary, rhinoorbital, and rhinoorbitocerebral. 3 .
In most cases of RCM, the fungi gain entry to the body via inhalation of airborne spores through the sinuses. It has been postulated that the most common reservoir for organisms is the pterygopalatine fossa. RCM begins with colonization of the nasal mucosa by airborne spores. In normal hosts, a phagocytic response to colonization prevents infection. In immunocompromised hosts, on the other hand, the response is suboptimal and germination ensues. 4 .Infection spreads along vascular and neuronal structures and infiltrates the walls of blood vessels. . Angioinvasion by the hyphae produces a fibrin reaction and the development of "mucor thrombi"
. which occlude the arteries and lead to ischemia, infarction, and consequent formation of the black necrotic eschar of the skin and mucosa that is characteristic of RCM. Vascular occlusion prevents systemic antifungal agents from reaching their targets, and ischemia favors the development of acidotic tissue, which is ideal for fungal growth. 5 . As the infection spreads it can erode bone through walls of the sinus and can spread into the orbit and the retro-orbital area, thereby extending into the brain.
Infection originating in the nose and paranasal sinuses may lead to blindness due to fungal invasion of the globe or ophthalmic artery, Cavernous sinus thrombosis, and Coma due to direct invasion of the frontal lobe 6. Without treatment, the patient may die within a few days to a few weeks. Patients who survive rhinocerebral mucormycosis are often left with severe facial disfigurement and usually require plastic surgery to restore their appearance..
We report a case of Rhino-cerebral Mucormycosis complicated by skull osteomyelitis , a rather unusual outcome because of the angioinvasive nature of the fungus.
Case report:
A 25 year old diabetic patient presented with the complaints of mild, continuous, global headache for 3 months which worsened on bending forward and straining and was not relieved by analgesics. This was followed by gradual swelling and numbness of face on right side .The Patient also complained of progressive dysphagia to liquid for the last two months. He also had low grade continued fever ten days prior to admission. He did not give any h/o diplopia, vomiting, blurring of vision, convulsion or loss of consciousness. There was no h/o cough, weight loss, bladder and bowel disturbances. He was a non smoker had no H/O exposure, abuse of alcohol . Before coming to Dhaka he was working as a farmer at KSA.
On examination patient was ill looking, mildly anaemic, temp 100 o F with facial puffiness, periorbital swelling and mild bilateral proptosis of eyes along with swelling & tenderness over right maxillary region. Neurological examination revealed slurred speech, bilateral papilloedema, fifth nerve palsy on right side, bilateral VI ,VII ,IX & X cranial nerve palsy. Fever is the most common early symptom (44% of cases), followed by nasal ulceration or necrosis, periorbital or facial swelling, and decreased vision, each of which occurs in approximately 33% of cases. . Ultimately, 80% of patients develop a necrotic lesion on either the nasal or oral mucosa.) When the clinical picture includes the presence of sinusitis with black discoloration in the nose and palate in addition to a predisposing factor, a diagnosis of RCM should be highly suspected .Other less frequent features include facial pain or numbness, nasal congestion or discharge, headache, ophthalmoplegia, anesthesia over the cheek, and cranialpolyneuropathy, which may be consistent with orbital apex syndrome. 13. A black eschar of the nasal mucosa or palate usually is a hallmark sign of rhinocerebral mucormycosis. It is a sign of deep infection and tissue destruction of the nasal mucosa. This finding on physical examination should prompt biopsy and empiric treatment. 14.
In our patient,presentation was with headache and right sided facial numbness followed by fever and dysphagia .On, examination,he had bilateral proptosis ,bilateral papillodema and bulbar weakness.The orbital manifestation preceeded intracranial spread; hence: Rhino-Orbito-Cerebral-Mucormycosis, was the most acceptable terminology.
Our patient later complained of severe headache with high grade fever complicated with a bony erosion. This sort of bony involvement is uncommon because of the angioinvasive nature of the fungus, and bone lesions are usually adjacent to other forms of mucormycosis. It has been described at the base of the cranium 15 , in the bones of the feet and hands [16] [17] [18] , and in the humerus 19] , tibia [20] , femur [21] and vertebrae [22] .
Definitive diagnosis requires identification of the fungus histologically in tissue specimens or recovery of the fungus by culture. 24 In our patient, PAS staining readily demonstrated the fungus (Mucor) in tissue taken from right Maxilllary and ethmoid sinuses.
Radiographic findings are helpful in assessing the different stages of the disease rather than in making a definitive diagnosis because the radiographic features may be indistinguishable from those of simple rhinosinusitis. 25 .In rhino-orbital-cerebral mucormycosis, CT generally shows evidence of paranasal sinus involvement manifested as mucosal thickening without air-fluid levels of several sinuses, primarily in the ethmoid and sphenoid sinuses, but with a clear unilateral predilection . 26 . Evidence of bone destruction on CT is a late finding, and usually is absent despite deep extension of disease beyond the bony confines of the paranasal sinus .
Because of the rapidity with which this disease progresses, prompt and aggressive therapy is essential 28 Three factors are key to a successful outcome of therapy for mucormycosis 29 1.Reversal of the underlying predisposition, 2. Aggressive surgical debridement, 3.Aggressive antifungal therapy, with early initiation and high drug doses.
Antifungal therapy alone or surgical therapy alone is ineffective The standard medical therapy for RCM is amphotericin B in a dose of 1.0 to 1.5 mg/kg/day should be continued for at least 3 months after: all clinical abnormalities resolve or stabilize, leaving no clinical evidence of infection at the involved site(s). Since the introduction of combined therapy with amphotericin B and surgery, more than 80% of the patients can be expected to survive 31 Recent data support the concept that high-dosliposomal amphotericin is the preferred monotherapy for mucormycosis as this formulation maximizes the amount of amphotericin B delivered to tissues as well as the speed of drug delivery and Nephrotoxicity occurs in < 50% of patients. So, Higher doses of liposomal amphotericin may be well-tolerated. 32 We treated our patient with Inj. Amphotericin-B, Cap. Fluconazole , and surgical debridement with some upportive therapy . The patient improved clinically his temperature subsided , puffiness of face and periorbital swelling reduced. We adviced continuation of Amphotericin B up to 2 gm & Fluconazole for 3 month and discharged the patient .
Conclusion :
Mucormycosis has a fulminantly fatal clinical pattern. We were able to modify the prognosis of our patient with rapid diagnosis, early and aggressive management including combined antifungal and surgical interventions, and reversal of underlying risk factors. In all cases a high index of sus
